Muljo Research Group

Our interdisciplinary team studies how the immune system develops and functions through the lens of RNA biology. We are interested in learning how gene expression programs are regulated post-transcriptionally with the goal of manipulating cell fate. As one application of our basic research on regulation of hematopoiesis during ontogeny, our group discovered how hematopoietic stem cells (HSCs) from an adult donor can be reprogrammed to behave like their fetal counterparts. This method provides an alternative source of HSCs from human fetal liver which one day could be used for in utero transplantation to cure inborn errors of immunity or hematopoiesis including but not limited to sickle cell disease, beta-thalassemia and many primary immunodeficiencies. 

Short Title
Muljo Research Group
Person List Page Type

Stefan Muljo, Ph.D.

Chief, Integrative Immunobiology Section

Education:

Ph.D., The Johns Hopkins University School of Medicine, Baltimore, MD

Dr. Muljo earned his Ph.D. from the Graduate Program in Immunology at The Johns Hopkins University School of Medicine. Part of his dissertation work was performed at the department of molecular and cell biology in the division of immunology and pathogenesis, University of California, Berkeley. This was followed by a postdoctoral fellowship at the Immune Disease Institute (formerly the Center for...

Learn more about Stefan Muljo, Ph.D.

Stefan Muljo, Ph.D.

Nicholas T. Cutrona, M.S.

Biologist

Education:

M.S., Georgetown University

Nicholas received his M.S. in Biochemistry and Molecular Biology from Georgetown University before joining NIAID in the Integrative Immunology section as a biologist in 2020. He has optimized RNA and DNA sequencing on short- and long-read platforms. Nicholas is interested in gene regulation during B cell development as well as regulation of MHC I expression.

Learn more about Nicholas T. Cutrona, M.S.

Zohirul Islam, Ph.D.

Postdoctoral Visiting Fellow

Education:

Ph.D., Osaka Prefecture University

Languages Spoken: Bangla

Dr. Zohir Islam received his Ph.D. from Osaka Prefecture University, Japan. There, he characterized the expression and function of an orphan G protein-coupled receptor Gpr137b in osteoclast differentiation and macrophage polarization. He developed an interest in RNA biology research, and in 2020, he joined Dr. Muljo’s Integrative Immunobiology group. Currently, he focuses on identifying RNA...

Learn more about Zohirul Islam, Ph.D.

Xiuhuai Liu, Ph.D.

Biologist

Education:

Ph.D., Scuola Normale Superiore, Pisa, Italy

Dr. Liu trained at NINDS as a postdoc and worked at NIMH as a research contractor, then joined NIAID as a biologist in 2011, and was the lab manager until 2014. He studies the roles of several genes on production and differentiation of fetal liver hematopoietic stem and progenitor cells (HSPCs) using knock-out, knock-in and transgenic mice.

Learn more about Xiuhuai Liu, Ph.D.

Patrick Thomas Smith, Ph.D.

Chemist (Lab Manager)

Education:

Ph.D., Texas A&M University
M.S., West Virginia University

Dr. Pat Smith received his Ph.D. from Texas A&M University, and trained at USDA before assuming a Chemist position at NIAID since 1992. He has over 35 years of research experience and is the lab manager of the Integrative Immunobiology section since 2014. He has developed a variety of techniques for immunological studies and supports the research of the team with his expertise. Pat is interested...

Learn more about Patrick Thomas Smith, Ph.D.

Sabrina Sultana, Ph.D.

Postdoctoral Visiting Fellow

Education:

Ph.D., Osaka Prefecture University

Languages Spoken: Bangla

Dr. Sultana received her Ph.D. from Osaka Prefecture University, Japan. There, her project focused on epidermal cell-patterning genes of Cuscuta campestris, a parasitic plant. She developed an interest in RNA biology research, and in 2021, she joined Dr. Muljo’s Integrative Immunobiology group. Currently, she is working to understand cell fate determination during fetal lymphopoiesis using mouse...

Learn more about Sabrina Sultana, Ph.D.

Alia Welsh, B.S.

Pre-Doctoral IRTA (NIH-OxCam MD-PhD student) 

Education:

M.D. (in progress), University of Illinois at Chicago, College of Medicine
B.S., University of California Los Angeles

Alia received her B.S. in Microbiology, Immunology, and Molecular Genetics from the University of California Los Angeles.

Learn more about Alia Welsh, B.S.

Former Research Group Members

Our alumni include but are not limited to: 

Hunter Oliver-Allen, M.D., Surgeon, Plastic Surgery Northwest, Spokane, WA, USA. 

Katsuya Suzuki, M.D., Associate Professor, Department of Internal Medicine (Rheumatology), School of Medicine, Keio University, Tokyo, Japan. 

Cuong Kieu Nguyen, Ph.D., Senior Staff Scientist, Institute of Population, Health and Development, Hanoi, Vietnam. 

Thelma Escobar, Ph.D., Assistant Professor of Biochemistry, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA. 

Brenna Brady, Ph.D., Project Director, Health Analytics, LLC, Columbia, MD, USA. 

Joan Yuan, Ph.D., Associate Professor, Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Lund University, Lund, Sweden. 

Madeline Wong, Ph.D., Staff Scientist, Center for Cancer Research Genomics Core, NCI, NIH, Bethesda, MD, USA. 

Young Uk Kim, Ph.D., Senior Scientist, Cellular Biomedicine Group, Inc., Rockville, MD, USA. 

Section
Content Manager
Content Coordinator
September 29, 2022

Desai Research Group

The Apicomplexan Molecular Physiology Section (AMPS) studies the cell and molecular biology of malaria parasites. We are focused on ion channels and transporters unique to these parasites and aim to develop novel antimalarial therapies against these targets.

Short Title
Desai Research Group
Person List Page Type

Sanjay Desai, M.D., Ph.D.

Chief, Apicomplexan Molecular Physiology Section

Specialty(s): Infectious Disease, Internal Medicine

Education:

M.D., Ph.D., Washington University in St. Louis

Dr. Desai received his M.D. and Ph.D. from Washington University in St. Louis. Following an internal medicine residency and infectious diseases fellowship at Duke University Medical Center, he joined the Division of Intramural Research. His work focuses on the molecular and cellular biology of malaria parasites.

Learn more about Sanjay Desai, M.D., Ph.D.

Photo of Sanjay Desai, M.D., Ph.D.

Lalana Appasani

Education:

University of Rochester

Lalana’s work is focused on improving DNA transfection of the human Plasmodium falciparum pathogen.

Learn more about Lalana Appasani

Portrait of Lalana Appasani

Jonathan Chu, B.S.

Education:

B.S., Biotechnology, Rochester Institute of Technology

Jonathan’s work is focused on calcium transport and utilization in human erythrocytes before and after infection with Plasmodium spp.

Learn more about Jonathan Chu, B.S.

Portrait of Jonathan Chu, B.S.

Zabdi Gonzalez, Ph.D.

Education:

Ph.D., National Autonomous University of Mexico

Dr. Gonzalez trained in molecular and biochemical parasitology, studying trypanothione-dependent metabolism of Trypanosoma cruzi. He is currently studying the structure and function of ion channel complexes in malaria parasites.

Learn more about Zabdi Gonzalez, Ph.D.

Portrait Zabdi Gonzalez, Ph.D.

Inderjeet Kalia, Ph.D.

Education:

Ph.D., National Institute of Immunology in New Delhi, India

Dr. Kalia trained in the molecular immunology of malaria infections. He is working to identify and characterize parasite ion channels in various stages of the malaria parasite life cycle.

Learn more about Inderjeet Kalia, Ph.D.

Portrait of Inderjeet Kalia, Ph.D.

Mohammad Kashif, Ph.D.

Education:

Ph.D., National Institute of Immunology in New Delhi, India

During his Ph.D., Dr. Kashif studied gametocyte formation, differentiation, heat shock responses, and drug targets in Plasmodium spp. He is currently studying transport of macromolecules in infected erythrocytes.

Learn more about Mohammad Kashif, Ph.D.

Portrait Mohammad Kashif, Ph.D.

Tatiane Macedo-Silva, Ph.D.

Education:

Ph.D., University of Sao Paulo, Brazil

Dr. Macedo-Silva trained in molecular biology and epigenetics of P. falciparum. She is now focused on calcium transport and utilization in malaria parasites.

Learn more about Tatiane Macedo-Silva, Ph.D.

Portrait of Tatiane Macedo-Silva, Ph.D.

Gagandeep Saggu, Ph.D.

Education:

Ph.D., BITS, Pilani, India

Dr. Saggu was trained in molecular parasitology, focusing on cell and molecular biology of bloodstream malaria parasites. His work is currently focused on biochemical and molecular studies of intracellular ion channels in the parasite.

Learn more about Gagandeep Saggu, Ph.D.

Portrait of Gagandeep Saggu, Ph.D.

Jinfeng Shao, Ph.D.

Education:

Ph.D., University of Groningen, Netherlands

Dr. Shao trained in protein X-ray crystallography with an emphasis on unnatural amino acid labeling. She is interested in structure-function studies, channel protein trafficking, and drug discovery targeting nutrient transport.

Learn more about Jinfeng Shao, Ph.D.

Portrait of Jinfeng Shao, Ph.D.

Mansoor Siddiqui, Ph.D.

Education:

Ph.D., ICGEB-Jawaharlal Nehru University, India

Dr. Siddiqui is trained in molecular and biochemical parasitology. He is now focused on the molecular basis and transport properties of intracellular ion channels in malaria parasites.

Learn more about Mansoor Siddiqui, Ph.D.

Portrait of Mansoor Siddiqui, Ph.D.
Section
Content Manager
Content Coordinator
September 29, 2022

Williamson Research Group

Cell Biology and Immunology of Fungal Infections

Short Title
Williamson Research Group
Person List Page Type

Peter Williamson, M.D., Ph.D.

Chief, Translational Mycology Section

Contact: williamsonpr@mail.nih.gov

Provides direct clinical care to patients at NIH Clinical Center

Education:

M.D., Ph.D., 1987, Boston University, Boston, MA

Dr. Williamson received his M.D./Ph.D. from Boston University in 1987 and completed a residency in internal medicine at Georgetown University before coming to the National Institutes of Health (NIH) for a fellowship in infectious diseases. In 1995, after serving a short stint as chief medical officer, Lalmba Sudan, Dr. Williamson joined the faculty at the University of Illinois at Chicago as an...

Learn more about Peter Williamson, M.D., Ph.D.

Photo of Peter Williamson, M.D., Ph.D.

Seher H. Anjum, M.D.

Staff Clinician

Specialty(s): Infectious Disease, Internal Medicine
Provides direct clinical care to patients at NIH Clinical Center

Education:

M.D., 2010, Kasturba Medical College, India

Seher Anjum MD is a Staff Clinician within the Translational Mycology Section of the Laboratory of Clinical Immunology and Microbiology (LCIM) at NIAID, NIH. She obtained an M.D. from Kasturba Medical College, India in 2010 after which she completed an internal medicine residency at the University of Missouri, Kansas City followed by an Infectious Disease fellowship at the University of Texas Medical Branch in Galveston, TX.

Learn more about Seher H. Anjum, M.D.

Waleed A. Elsegeiny, Ph.D.

Postdoctoral Fellow

Education:

Ph.D., University of Pittsburgh School of Medicine

B.S., Louisiana State University

Languages Spoken: Arabic

Our clinical study focuses on non-HIV individuals that acquire an opportunistic infection of Cryptococcus. Over 30% of patients tested were positive for anti-GMCSF autoantibodies in blood plasma. One function of GM-CSF is the inhibition of autophagy in monocytes/macrophages, which we observed enhances their sensitivity to antigen, cytokine production, and intrinsic fungicidal activity.

Learn more about Waleed A. Elsegeiny, Ph.D.

Photo of Waleed A. Elsegeiny, Ph.D.

Jessica C. Hargarten, Ph.D.

Postdoctoral IRTA Fellow

Education:

Ph.D., Biological Sciences, 2016, University of Nebraska, Lincoln
B.S., Biological Sciences, 2009, University of California, Davis

Jessica’s research in the TMS focuses on understanding how rare genetic variants (in MTOR, GPR35, and CXCR6) increase the susceptibility of previously healthy people to fungal infections, particularly those caused by the neurotropic pathogen Cryptococcus. Ongoing experiments using mouse models of disease and clinical samples will further determine the role of these genes in immunity and...

Learn more about Jessica C. Hargarten, Ph.D.

Photo of Jessica C. Hargarten, Ph.D.

Guowu Hu, Ph.D.

Biologist

Languages Spoken: Chinese

My research interests focus on the role of autophagy in the pathogenesis of fungal infectious diseases in human.

Learn more about Guowu Hu, Ph.D.

Yoon-Dong Park, Ph.D.

Education:

Ph.D., Chungnam National University

Languages Spoken: Korean

The aim of my research is the study of molecular mechanisms of virulence in fungal infectious diseases to elucidate novel therapeutic approaches for prevention and treatment. My recent research focus is to find a biomarker of cryptococcal meningitis and use it for therapy by comparing the gene expression of meningitis and pneumonia.

Learn more about Yoon-Dong Park, Ph.D.

Jin Qiu, M.D., Ph.D.

Biological Scientist; Lab Manager

Education:

M.D., Ph.D., Xinjiang Medical University, Urumqi; Beijing University of Chinese Medicine, Beijing; Peking Union Medical College, Beijing.

Languages Spoken: Chinese

Focuses on pathogenesis, diagnosis, treatment, prevention, and epidemiology of mycoses, particularly cryptococcosis and candidiasis. Try to demonstrate a role for MUC16/CA125 in the initial adhesion events in vascular kidney endothelial cells and a potential role for serum measurements as a marker of outcome in human fungal infections.

Learn more about Jin Qiu, M.D., Ph.D.

Terri L. Scott, MSN, CRNP-F

Nurse Practitioner

Education:

MSN Family Nurse Practitioner, Chamberlain University

Support the Translational Mycology Section by evaluating patients enrolled on our natural history protocol in an outpatient setting. Contribute to research by compiling clinical data for publications.

Learn more about Terri L. Scott, MSN, CRNP-F

Photo of Terri L. Scott, MSN, CRNP-F

Kenneth Ssebambulidde, MBChB, M.Sc

Education:

M.Sc., Immunology of Infectious Diseases, 2019, London School of Hygiene and Tropical Medicine

MBChB, 2015 Makerere University, College of Health Sciences, Kampala, Uganda

Languages Spoken: Luganda

I am a clinician with special interest in immune-mediated etiopathogenesis of diseases including a link between communicable and non-communicable diseases. I am a visiting postdoc fellow under the African Postdoctoral Training Initiative (APTI) program. Currently in Dr Williamson’s lab, I am working on understanding the role of CD151, a cell membrane tetraspanin, in the pathogenesis of...

Learn more about Kenneth Ssebambulidde, MBChB, M.Sc

Malcolm J. Vaughan

Research Support Specialist

Education:

B.S., Biological Sciences

I primarily assist with the various animal studies and colony management within the lab. The other project I work on is testing the efficacy of treatment cochleates in cells and animal studies.

Learn more about Malcolm J. Vaughan

Nannan Zhang, Ph.D.

Biologist

Education:

Ph.D., Biology, Johns Hopkins University

M.S., Biochemistry and molecular biology, Dalian Medical University

B.S., Clinical Medicine, Dalian Medical University

Languages Spoken: Chinese

Working on an RNA biology project related to cryptococcal infection and autoimmune diseases. It involves exploring functions of a RNA helicase, DDX6 in fungal infection and naïve T cell polarization.

Learn more about Nannan Zhang, Ph.D.

Section
Content Manager
Content Coordinator
September 28, 2022

Lobanenkov Research Group

The Molecular Pathology Section study paralogous DNA binding proteins CTCF and BORIS (also known as CTCFL) in 3D genome organization and gene regulation in normal and pathological contexts including; spermatogenesis, evolution, development and cancer.

Short Title
Lobanenkov Research Group
Person List Page Type

Victor Lobanenkov, Ph.D.

Chief, Molecular Pathology Section

Contact: Victor Lobanenkov, Ph.D.

Education:

Ph.D., 1981, Cancer Research Center, Moscow

M.A., 1977, Institute of Physics, UK

Dr. Lobanenkov received an M.A. in nuclear physics from the Institute of Physics in 1977 and a Ph.D. in experimental oncology from the Cancer Research Center, Moscow, in 1981. He was molecular carcinogenesis team leader in the All-Union Cancer Center of the former U.S.S.R. and a visiting scholar at the Royal Cancer Hospital, London, until 1990, where he discovered avian CTCF. He was invited to the...

Learn more about Victor Lobanenkov, Ph.D.

Victor Lobanenkov, Ph.D.

Liron M. Fedida, B.A.

Post Baccalaureate

Education:

B.A., City University of New York, Queens College, United States

Languages Spoken: Hebrew

Liron joined the group in 2021. His major project is to investigate the molecular pathology of CTCF mutations that are associated with neurodevelopmental disorders. His interests lie in clinical neuroscience and biology. He aspires to attend medical school.

Learn more about Liron M. Fedida, B.A.

Yon Ji, Ph.D.

Senior Research Associate

Education:

Ph.D., Gwangju Institute of Science and Technology, South Korea

Languages Spoken: Korean

Yon joined Dr. Lobanenkov’s group in 2021 as a senior research associate and works on several research projects. A major focus is the search of protein-partners, which are involved in 3D genome organization together with CTCF and cohesin. Yon utilizes cell biology assays, CRISPR genome editing and next-generation sequencing (NGS) techniques to gain insights into the regulation of 3D chromatin...

Learn more about Yon Ji, Ph.D.

Dmitri Loukinov, Ph.D.

Staff Scientist

Education:

Ph.D., Institute of Biochemistry, Ukrainian Academy of Sciences, Ukraine

Languages Spoken: Ukrainian, French, Russian

Dmitri works on several projects involving CTCF and BORIS that relate to 3D organization of genome, activation/repression of transcription, imprinting control, X chromosome inactivation & transgenerational inheritance. A current major interest is the clinical application of BORIS as an immune target to create personalized vaccines for the treatment of breast and other cancers.

Learn more about Dmitri Loukinov, Ph.D.

Emma Price, Ph.D.

Visiting Fellow/Postdoctoral Research Fellow

Education:

Ph.D., Institute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom

Emma joined the group in 2020 and leads a project to study the functional role of CTCFL in spermatogenesis. She has established a novel humanized CTCFL mouse model and developed protocols utilizing next-generation sequencing (NGS) technologies to study 3D genome organization in germ cells. Her research interests are epigenetics, transposable elements and transgenerational inheritance.

Learn more about Emma Price, Ph.D.

Elena M. Pugacheva, Ph.D.

Staff Scientist

Education:

Ph.D., Faculty of Biology, Lomonosov Moscow State University, Russia

Languages Spoken: Russian

Elena studies the involvement of two paralogous proteins, CTCF and BORIS/CTCFL in 3D genome organization, transcriptional regulation of gene expression, transgenerational epigenetic inheritance, and epigenetic resetting in normal and cancer cells. Her approach is to study single examples of gene regulation in detail and then extend the analysis on a genome-wide level, incorporating multiple next...

Learn more about Elena M. Pugacheva, Ph.D.

Kaushlendra Tripathi, Ph.D.

Education:

Ph.D., Centre for Cellular & Molecular Biology, India

Languages Spoken: Hindi

Dr Tripathi joined the group in 2022. His main interests are DNA replication, cancer stem cells, cell cycle regulation and DNA damage response in various cancers and their inhibitors. His main research project focuses on deciphering the role of hypoxia induced myeloma derived exosomes and chemo-exosomes in angiogenesis and chromosome looping. He is also currently working on the role of BORIS in...

Learn more about Kaushlendra Tripathi, Ph.D.

Section
Content Manager
Content Coordinator
September 28, 2022

Xu Research Group

Dr. Xu’s group has a long-term interest in G protein-coupled receptors (GPCRs)’ signaling in chemotaxis of eukaryotic cell, metastasis of cancer cells, and viral infections, such as human immunodeficiency virus (HIV) infections and current COVID-19. Chemotaxis is directional cell migration guided by extracellular chemoattractant gradients. This cellular behavior of eukaryotic cells plays a critical role in many physiological processes, such as embryogenesis, neuron patterning, angiogenesis, innate immune responses to infections, metastasis of cancer cells, and the early development of the model organism Dictyostelium. Both Dictyostelium and neutrophil use G protein-coupled receptors (GPCRs), the largest groups of receptors in eukaryotic organisms that play pivotal roles in many processes closely related to human health and disease, to sense and move toward higher concentrations of extracellular chemoattractants. Applying state-of-art imaging technologies, Dr. Xu’s research proposed and identified locally recruited Ras inhibitors, C2GAP1 and CAPRI in Dictyostelium and human neutrophils, respectively, as essential players in GPCR-mediated Ras adaptation, gradient sensing, and cell sensitivity. Her discoveries suggest an evolutionarily conserved mechanism by which eukaryotic cells gate sensitive concentration ranges of chemoattractant for chemotaxis.

Short Title
Xu Research Group
Person List Page Type

Xuehua Xu, Ph.D.

Senior Associate Scientist, Chemotaxis Signal Section

Specialty(s): Allergy and Immunology, Infectious Disease, Pathology, Medical Microbiology

Education:

Ph.D., Tsukuba University, Japan

B.S., M.S., Harbin Normal University, China

Dr. Xuehua Xu obtained her bachelor’s and master’s degrees in biology from Harbin Normal University, China, and her Ph.D. in biotechnology from Tsukuba University, Japan. In 2006, she was recruited as an assistant professor at the Georgetown University School of Medicine. In 2010, she was recruited to NIH as a staff scientist in Dr. Jin’s group. She was promoted to Associate Scientist in 2019 and Senior Scientist in 2021.

Learn more about Xuehua Xu, Ph.D.

Photo of Xuehua Xu, Ph.D.

HyunGee Ha, B.S.

IRTA fellow

Education:

B.S., University of Maryland

Languages Spoken: Korean

PLCg2–mediated IP3 Dynamics in Neutrophil-Like HL60 Cells Using IP3 FRET Probe by Confocal Microscopy.

Learn more about HyunGee Ha, B.S.

Hyungee Ha, IRTA Fellow
Section
Content Manager
Content Coordinator
September 28, 2022

Lisco Research Group

Primary and acquired immunodeficiencies like HIV/AIDS are associated with a high prevalence of skin and mucosal diseases caused by the Human Papillomaviruses (HPV), as well as an accelerated progression to HPV-related cancers. Dr. Lisco`s primary focus is on delineating the genetic, immunological, and molecular determinants of the persistence, regression, or progression of HPV-related diseases to inform innovative preventive and therapeutic strategies. The translational workflow of the laboratory is based on the integration of clinical protocols focused on the identification of clinical and epidemiological predictors of severe HPV-related diseases with studies on host genetics and tissue-specific immunopathogenesis at the skin and mucosal barriers, eventually informing personalized interventional clinical protocols.

Short Title
Lisco Research Group
Person List Page Type

Andrea Lisco, M.D., Ph.D.

Chief, Mucosal and Cutaneous Viral Immunopathogenesis Unit 
Lasker Clinical Research Scholar

Education:

M.D., University of Bari, Italy

Ph.D., University of Padua, Italy

Dr. Lisco earned his medical degree at University of Bari, Italy and pursued his research interests in viral immunology and pathogenesis of oncogenic viruses during his Ph.D. at the University of Padua, Italy and post-doctoral fellowship at the National Institutes of Health.

Learn more about Andrea Lisco, M.D., Ph.D.

Andrea Lisco, M.D., Ph.D

Derek MacMath, M.D.

Clinical Fellow

Education:

B.S., 2014, Molecular and Cellular Biology, Italian, Johns Hopkins University, Baltimore, MD

M.D., 2019, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Internal Medicine/Pediatrics Residency, 2023, Baylor College of Medicine/Texas Children’s Hospital, Houston, TX

Dr. MacMath earned his medical degree at the University of Pennsylvania Perelman School of Medicine and completed his residency in internal medicine and pediatrics at Baylor College of Medicine. He is a clinical fellow in the NIAID Allergy & Immunology Fellowship Program.

Learn more about Derek MacMath, M.D.

Photo of  Derek MacMath, M.D.

Amay Shah, B.S.

Postbaccalaureate IRTA Fellow

Education:

B.S., 2023, Human Biology and Society + Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles

Amay Shah is currently working with Dr. Andrea Lisco on clinical and translational research focused on observing T-cell responses to HPV in patients with primary and acquired immunodeficiencies. His current project involves observing the HIV Reservoir in HPV-specific T cells and characterizing T-cell responses to HPV in patients with HPV and HIV co-infection.

Learn more about Amay Shah, B.S.

Peiying Ye, Ph.D.

Biologist

Languages Spoken: Chinese

Mapping the host determinants of HPV-related diseases in immunocompromised hosts (EPIC). Development of novel preventive and therapeutic strategies for severe HPV-related disease (NEPTUNE).

Learn more about Peiying Ye, Ph.D.

Peiying Ye, Ph.D., Biologist
Section
Content Manager
Content Coordinator
January 08, 2025

Rao Research Group

Investigation of non-malignant lymphoproliferative disorders associated with cytopenias and targeted therapies.

Short Title
Rao Research Group
Person List Page Type

V. Koneti Rao, M.D., FRCPA

Senior Research Physician, Primary Immune Deficiency Clinic (ALPS Clinic)

Contact: V. Koneti Rao, M.D., FRCPA

Specialty(s): Hematology, Pediatrics
Provides direct clinical care to patients at NIH Clinical Center

Education:

M.D., S.C.B. Medical College and Hospital, Cuttack, India

Dr. Rao received his undergraduate and pediatric post-graduate medical education at SCB Medical College (Cuttack, Odisha, India) followed by Hematology training at the CMC Hospital (Vellore, India) and the Tata Memorial Hospital (Mumbai, India). Dr. Rao then undertook specialized training through a Hematology fellowship in Australia at Westmead and Sydney Children’s Hospital, followed by a...

Learn more about V. Koneti Rao, M.D., FRCPA

V. Koneti Rao, M.D., FRCPA

Elaine Kulm, MS, CRNP, CPNP-AC, CPHON

Nurse Practitioner

Education:

M.S., School of Nursing, University of California San Francisco
B.S.N., School of Nursing and Health Studies, Georgetown University

Alan Orpia, BSN, RN

Study Coordinator

Education:

University of the Philippines

Former Research Group Members

Susan Price, BSN, RN - retired 

Sharon Webster, BSN, RN – retired 

Elaine Smoot, MSN, RN - retired 

Section
Content Manager
Content Coordinator
September 28, 2022

Khoury Research Group

The Eosinophil Clinical Research Unit develops translational and clinical protocols for study of eosinophilic disorders. Through comprehensive trainee and investigator mentoring as well as partnering with highly trained research coordinators, nurses, clinical providers, as well as patient advocates and research participants, ECRU oversees and implements protocols to study a range of eosinophil-related disorders. The types of protocols implemented include novel diagnostic, therapeutic, and interventional approaches to study of eosinophil associated pathogenesis. The eosinophil clinical research unit also studies the application of augmented intelligence/machine learning approaches in allergic and immunologic diseases.  

Short Title
Khoury Research Group
Person List Page Type

Paneez Khoury, M.D., M.H.Sc., FAAAAI

Senior Clinician; Director, Allergy & Immunology Fellowship Training Program, Laboratory of Allergic Diseases (LAD)
Head, Eosinophil Clinical Research Unit, Human Eosinophil Section, Laboratory of Parasitic Diseases (LPD)

Specialty(s): Allergy and Immunology, Internal Medicine
Provides direct clinical care to patients at NIH Clinical Center

Education:

M.D., University of Illinois College of Medicine, Chicago, IL

M.H.Sc., Duke University, Durham, NC

Paneez Khoury, M.D. is Senior Clinician in NIAID. She has been involved in translational research in eosinophilic disorders since joining the Human Eosinophil Section in 2012. She is the head of the Eosinophil Clinical Research Unit in the Human Eosinophil Section where she leads clinical investigative trials and studies in a variety of eosinophilic disorders. She received her M.D. from University...

Learn more about Paneez Khoury, M.D., M.H.Sc., FAAAAI

A headshot of Paneez Khoury in a lab coat.

Amari Howard, M.D.

Education:

Residency, Jefferson/A.I. DuPoint 
Medical School, University of Pittsburgh 
Undergraduate, Syracuse University

Dr. Amari Howard is a gastroenterology fellow trainee at Children’s National Medical Center performing research in the eosinophil clinical research unit. Her clinical and research interests are in IBD and EGIDs. She is involved in the development and implementation of a CEGIR/NCATS funded pilot assessment of gastric motility abnormalities in patients with eosinophilic gastritis.

Learn more about Amari Howard, M.D.

Portrait of Amari Howard M.D.

Meghan Koch, B.S.

Education:

B.S., Colorado College

Megan Koch is an INRO student who is involved in the conduct of projects surrounding eosinophilic gastrointestinal disorders including a natural history study of eosinophilic gastrointestinal diseases (EGIDs). She is also involved in the CEGIR/NCATS funded pilot assessment of gastric motility abnormalities in patients with eosinophilic gastritis. Her projects spans laboratory and clinical aspects...

Learn more about Meghan Koch, B.S.

Portrait of Meghan Koch, B.S.
Section
Content Manager
Content Coordinator
September 28, 2022

Loke Research Group

Our research goal is to understand the heterogeneity of type-2 immune responses during helminth infections. An appropriately regulated type-2 response is critical in maintaining the balance between expelling enough parasites and tolerating the remaining parasites without excessive collateral tissue damage, in order to maintain the fitness of the host. The mechanisms underlying the heterogeneity of type-2 responses between individuals still remains poorly understood. Our basic immunological studies on macrophage biology and our translational research studies on the microbiota are converging toward the goal of understanding factors that regulate variation of type-2 immune responses in humans. Using a combination of mouse models, as well as field and clinical studies, our future plans are to test some of the concepts that we have developed on chromatin remodeling in macrophage responses to type-2 cytokines, as well as helminth-microbiota interactions, in mouse models, field studies and also human challenge infections.

Short Title
Loke Research Group
Person List Page Type

P’ng Loke Ph.D.

Chief, Type 2 Immunity Section

Education:

Ph.D., 2001, University of Edinburgh, UK

Dr. P’ng Loke completed his Ph.D. research at the University of Edinburgh on IL-4 activated macrophages responding to Brugia malayi filarial parasites in 2001. He then did postdoctoral research on costimulatory molecules at University of California-Berkeley and studied macrophage responses to different parasites at University of California-San Francisco. In 2009, he joined New York University School of Medicine as an assistant professor and was a tenured associate professor before he joined the Laboratory of Parasitic Diseases as a senior investigator in 2020.

Learn more about P’ng Loke Ph.D.

Headshot of P'ng Loke

Camila de Oliveira Silva e Souza, Ph.D.

Postdoctoral Visiting Fellow

Portrait of Camila de Oliveira Silva e Souza, Ph.D.

Nina Grace Howard

Post-bac IRTA

Portrait of Nina Grace Howard

Kasalina Kiwanuka, Ph.D.

IRTA Postdoctoral Fellow

Portrait of Kasalina Kiwanuka, Ph.D.

Soo Ching Lee, Ph.D.

Postdoctoral Visiting Fellow

Education:

Ph.D., 2014, Universiti Malaya

Portrait of Soo Ching Lee, Ph.D.

Jean Pierre Kambala Mukendi, M.D., Ph.D.

Postdoctoral Visiting Fellow

Portrait of Jean Pierre Kambala Mukendi, M.D., Ph.D.

Oyebola Oyesola, DVM, Ph.D.

NIH Independent Research Scholar

Education:

Ph.D. Immunology and Infectious Disease, Cornell University

M.Sc. Infection and Immunity, University of Leicester

DVM Doctor of Veterinary Medicine, University of Ibadan

Dr. Oyesola obtained her Veterinary Degree (DVM) from the University of Ibadan, Nigeria graduating with several distinctions at the end of her study at Ibadan. Motivated by her interest to better understand diseases of global and zoonotic importance, Dr. Oyesola pursued a postgraduate MSc. training in Infection and Immunity at the University of Leicester as a Commonwealth Shared Scholar. Following this, as a recipient of the Cornell African Scholar and Graduate Research Award, she obtained her Ph.D in Immunology and Infectious Disease at the Cornell University College of Veterinary Medicine. Her dissertation work in the Tait-Wojno lab focused on dissecting the role of prostaglandin D2 in the regulation of mucosal responses during Type 2 inflammation.

Learn more about Oyebola Oyesola, DVM, Ph.D.

Portrait of Oyebola Oyesola, DVM, Ph.D.

Octavio Mondragon Palomino, Ph.D.

Biologist

Portrait of Octavio Mondragon Palomino, Ph.D.

Mingming Zhao, M.D., Ph.D.

Biologist

Portrait of Mingming Zhao, M.D., Ph.D.

Former Research Group Members

Kimberly Zaldana
Post-bac IRTA
(Currently in PhD program at NYU)

J. Cooper Devlin
Ph.D. Student
(Currently Associate Scientist at Regeneron)

Jian-Da Lin, Ph.D.
Staff Scientist
(Currently Assistant Professor, National Taiwan University)

Rowann Bowcutt, Ph.D.
Postdoctoral Fellow
(Currently Senior Principal Scientist. UCB Pharma)

Uma Mahesh Gundra, Ph.D.
Postdoctoral Fellow
(Currently Senior Scientist, EMD Serono)

Natasha Girgis, Ph.D.
Postdoctoral Fellow
(Currently Associate Director, Translational Pharmacology Cue Biopharma)

Mei San Tang, Ph.D.
Postdoctoral Fellow
(Currently Transfusion Medicine Fellow, Department of Pathology, Stanford University)

Michael Gonzalez
PhD Student
(Currently Scientist, Gilead)

Mara Jana Broadhurst
MD-PhD Student
(Currently Assistant Professor, University of Nebraska)

Jordan Poles
High school Student and Medical Student
(Currently Resident Physician, NYU)

Michael Davenport
Medical Student
(Currently Clinical Assistant Professor of Medicine, UPenn)

Martin Wolff
Clinical Research Fellow
(Currently Clinical Assistant Professor of Medicine, NYU)

Jacqueline Leung
Research Technician
(Currently, Immunology Scientist, Verily)

Section
Content Manager
Content Coordinator
September 28, 2022

Lusso Research Group

The Viral Pathogenesis Section (VPS) is focused on the study of HIV/AIDS pathogenesis and the development of innovative strategies for therapy and vaccine. A primary area of interest in recent years has been the development of a novel HIV-1 vaccine platform based on mRNA. Another research topic, directly related to vaccine design, is the elucidation of the structure-function relationships within the HIV-1 envelope glycoproteins, which can identify conserved functional regions and elucidate the structural basis of immune evasion, a major obstacle to vaccine development. This knowledge has also been instrumental to the VPS efforts to rationally engineer HIV-neutralizing antibodies with improved potency and breadth. Other research areas include the study of endogenous immune modulators that regulate HIV-1 transmission, replication, and pathogenesis, including CCR5-binding antiviral chemokines, interleukin-7 and integrin α4β7. The research group uses a comprehensive research approach that combines classic immunology and virology with state-of-the-art post-genomic technologies and pre-clinical in vivo studies in nonhuman primates. 

Short Title
Lusso Research Group
Person List Page Type

Paolo Lusso, M.D., Ph.D.

Chief, Viral Pathogenesis Section

Contact: plusso@niaid.nih.gov

Education:

PH.D., Ministry of Scientific and Technologic Research, Rome, Italy
M.D., University of Turin, Turin, Italy

Dr. Lusso received his M.D., summa cum laude, from the University of Turin and his Ph.D. from the Ministry of Scientific and Technologic Research, Rome, Italy. He is a board-certified specialist in internal medicine and in infectious diseases. He came to NIH for the first time in 1986 to work in the Laboratory of Tumor Cell Biology under Dr. Robert C. Gallo at the National Cancer Institute. He...

Learn more about Paolo Lusso, M.D., Ph.D.

Paolo Lusso, M.D., Ph.D.

Qingbo Liu, Ph.D.

Research Fellow

Languages Spoken: Mandarin, Chinese

Qingbo Liu’s research is focused on the structural and functional study of the HIV-1 envelope trimer. He utilized structure-based rational design to optimize HIV neutralizing antibodies and antigens for HIV treatment and prevention. He is also conducting pre-clinical studies evaluating the antiviral molecules in animal models.

Learn more about Qingbo Liu, Ph.D.

Portrait of Qingbo Liu, Ph.D.

Hana Schmeisser, Ph.D.

Staff Scientist

Languages Spoken: Slovakian

The major focus of Dr. Schmeisser’s research is to study: The immunomodulatory effects of IL-7 and its role in antiviral defenses; The receptors and signaling pathways involved in IL-7-mediated induction and production of chemokines and cytokines; The pro-inflammatory effects of type-I IFN and TNF during the chronic phase of HIV-infection; The development of neutralizing antibodies against type-I...

Learn more about Hana Schmeisser, Ph.D.

Portrait of Hana Schmeisser, Ph.D.

Mamta Singh, Ph.D.

Postdoctoral Fellow

Languages Spoken: Hindi

During her Ph.D. studies, Dr. Singh evaluated biodegradable polymeric nanoparticles as a vaccine delivery platform for improving the immunogenicity of polysaccharide antigens. Presently, her research work aims to elucidate the mechanisms of action of mRNA vaccines against HIV-1 that produce virus-like particles (VLPs) and to develop slow-release platforms for such vaccines.

Learn more about Mamta Singh, Ph.D.

Portrait of Mamta Singh, Ph.D.

Peng Zhang, Ph.D.

Staff Scientist

Languages Spoken: Mandarin, Chinese

Peng Zhang’s research Interests include the structure-based design and development of novel HIV-1 vaccine immunogens; the evaluation of investigational vaccines for immunogenicity and efficacy; the isolation and characterization of HIV-neutralizing antibodies; the use of pre-clinical models to test experimental vaccines and move them toward clinical evaluation.

Learn more about Peng Zhang, Ph.D.

Portrait of Peng Zhang, Ph.D.
Section
Content Manager
Content Coordinator
September 28, 2022